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The objective of this study was designed to test whether supplementation 
of the diet with arginine (Arg) or glutamine (Gln) or their combination influences 
the production, organ weights and humoral immune response of broilers. A total 
of 432 one-day-old male Ross 308 broiler chickens were divided into 6 treatment 
groups: control, Arg-0.5%, Arg-1%, Gln-0.5%, Gln-1% and Arg-0.5%+Gln-0.5%. 
Drinking water and feed were provided ad libitum. On day 18 of the experiment 
50% of chickens in each treatment group were immunised with bovine serum al-
bumin. Ten and 21 days after immunisation blood samples were collected to de-
termine the anti-albumin IgY titre, interleukin 6 (IL6) and interferon gamma 
(IFNG) and to measure the weight of the liver, spleen, bursa of Fabricius and 
thymus. Arg or Gln supplementation of the diets influenced neither the production 
nor the organ weights until 18 days of age. Between 18 and 39 days of age both 
Arg (0.5% and 1%) and Arg + Gln supplementation improved the feed conversion 
ratio (FCR) by 3.7%, 6.3% and 4.9%, respectively, while Gln-1% worsened it by 
15%. Immunisation slightly (–0.79%) depressed the body weight gain of broilers 
fed the control diet, which was significantly improved by both Arg (0.5 or 1%) 
and Arg + Gln supplementation. Immunisation increased the weight of the spleen, 
bursa and thymus and decreased that of the liver. Supplementation with 1% Gln 
depressed (–5.13%) the body weight gain of the immunised chickens but strongly 
stimulated the immune response. Supplementations with Arg and Gln did not in-
fluence the IL6 and IFNG level of the blood; however, on day 10 after immunisa-
tion these two parameters showed a negative correlation with each other. Regard-
ing production, organ weights and immunity, Arg supplementation should be rec-
ommended in the grower phase, while Gln supplementation can be useful in pul-
lets raised for egg production, where a good immune response to vaccinations is 
an important factor. 
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After the ban of antibiotic growth promoters (AGPs) in the European Un-
ion (2006) there has been a need to identify and implement practical alternatives 
for AGPs to prevent infectious diseases and increase the production of broilers. 
Immunological intervention may be one of the useful possibilities to reduce mi-
crobial pathogens and improve the production parameters. Bioactive food com-
ponents may interact with the immune response and increase the resistance of 
food-producing animals to infectious diseases. For example, some major classes 
of nutrients including amino acids such as arginine (Arg) (Kidd et al., 2001) and 
glutamine (Gln) (Soltan, 2009) may improve growth, performance, development 
of the gastrointestinal tract and the immune response. 
Arginine is classified as a semi-essential amino acid, which functions as 
an intermediate in the urea cycle in several species and is a substrate for several 
compounds containing non-protein nitrogen. In chickens, dietary Arg is used 
only for the synthesis of protein and metabolically important molecules such as 
creatine. The metabolic Arg requirement of chickens does not include the urea 
cycle function because the main waste product of nitrogen metabolism in chicken 
is uric acid, the formation of which does not require Arg. It has also been shown 
that Arg is an essential amino acid for chickens (Arnold et al., 1936; Klose et al., 
1938) because of the lack of detectable mitochondrial carbamoyl phosphate syn-
thetase I enzyme in all tissues (Klose and Almquist, 1940). The Arg requirement 
of broilers is among the highest, due to the lack of endogenous synthesis and the 
high growth capacity. Under certain physiological or stress situations, dietary 
Arg may not be sufficient, and the consequence can be suboptimal weight gain 
and/or insufficient immune response to viral or bacterial antigens. Tayade et al. 
(2006) showed that Arg supplementation increased protection against infectious 
bursal disease virus challenge, showing the beneficial effect of this amino acid 
on immune functions. A similar observation has been reported by Munir et al. 
(2009) both for the humoral and the cellular immune response. 
Glutamine is a non-essential amino acid, which accounts for 30–40% of 
the amino acids in the plasma (Newsholme et al., 1985). It is involved in protein, 
peptide and nucleic acid synthesis. Gln is distributed to the intestinal mucosa by 
arterial circulation and is a critical nitrogen source for rapidly dividing cells such 
as those of the intestinal mucosa, and may be the most important fuel for the mu-
cosa (Wu, 1998). Supplementation of the diet with Gln may increase the length 
of villi in the small intestine (Soltan, 2009). Glutamine can act as an ‘N shuttle’, 
protecting the body from high levels of ammonia (Labow, 2001), and it is an im-
portant metabolic fuel in immune nutrition (Andrews and Griffiths, 2002; Li et 
al., 2007). 
Since both Arg and Gln may be limiting regarding growth, performance 
and immune response in broilers, this study was designed to test whether sup-
plementation of the diet with either of these two amino acids or their combina-
tion improves production (body weight, feed intake, feed/gain ratio), influences 
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the weight of organs (liver, spleen, thymus and bursa of Fabricius) and the hu-
moral immune response (anti-albumin IgY-titre, IL6 and IFNG levels) of broil-
ers. 
Table 1 
Chemical composition of the diets 
Parameters Starter (days 0–21) 
Grower 
(days 22–35) 
Finisher 
(days 36–39) 
AMEn (MJ/kg) 13.1 13.1 13.5 
Dry matter (%) 90.0 89.9 90.4 
Ash (%) 6.04 6.37 6.23 
Crude protein (%) 22.8 20.0 17.6 
Ether extract (%) 3.03 4.54 4.93 
Crude fibre (%) 3.11 3.81 3.00 
Amino acid composition of the control diets (%) 
Lys 1.45 1.13 1.03 
Met 0.47 0.31 0.33 
Cys 0.14 0.11 0.11 
Thr 1.07 0.73 0.70 
Arg 1.53 1.25 1.10 
Val 0.75 0.54 0.50 
Ile 0.73 0.53 0.51 
Leu 2.41 1.58 1.50 
His 0.59 0.46 0.43 
Asp 2.62 2.04 1.86 
Ser 1.44 1.04 0.95 
Glu + Gln 4.23 3.33 3.05 
Gln 0.46 0.39 0.33 
Pro 1.68 1.07 1.07 
Gly 1.05 0.80 0.73 
Ala 1.42 0.94 0.90 
Tyr 0.99 0.71 0.65 
Phe 1.25 0.88 0.82 
Σ 23.84 17.47 16.25 
 
 
Materials and methods 
A total of 432 one-day-old male Ross 308 broiler chickens were used. The 
birds were housed in an environmentally controlled room according to the stan-
dard broiler management practice of Ross (Ross Broiler Management Manual, 
Aviagen, 2009). The commercial broiler diets were purchased from Farmer-Mix 
Ltd. (Zsámbék, Hungary). L-arginine and glutamine (at least 99% pure) were 
purchased from retail outlets. Feed and water were supplied ad libitum. The 
chemical composition (Table 1) of the diets used in the experiment was deter-
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mined according to the AOAC (1990) prescriptions. Amino acids of the diets 
were determined after acid hydrolysis by ion-exchange chromatography. Chro-
matography was performed using an AAA 400 amino acid analyser (Ingos Ltd., 
Czech Republic) equipped with an Ostion LG ANB ion-exchange column. 
The chickens were randomly divided into 6 groups (72 birds per group), 
with 6 replicates (12 birds/replicate) in each dietary treatment group as indicated 
in Table 2. The experiment was divided into two phases. In phase one (from day 
0 to day 18) the chickens were not immunised and in phase 2 (from day 19 to day 
39) 50% of the broilers in each treatment group were immunised. 
Table 2 
Treatment groups used in the experiment 
Phase 1 (days 0–18) Phase 2 (days 19–39) 
Treatments 
Starter (days 0–21) Grower (days 22–35) Finisher (days 36–39) 
Non-immunised (Control) Control Non-immunised12 replicates Immunised (I-Control) 
Non-immunised (Arg-0.5%) Arg-0.5% Non-immunised12 replicates Immunised (I-Arg-0.5%) 
Non-immunised (Arg-1%) Arg-1% Non-immunised12 replicates Immunised (I-Arg-1%) 
Non-immunised (Gln-0.5%) Gln-0.5% Non-immunised12 replicates Immunised (I-Gln-0.5%) 
Non-immunised (Gln-1%) Gln-1% Non-immunised12 replicates Immunised (I-Gln-1%) 
Non-immunised (Arg-0.5%+Gln-0.5%) 
Arg+Gln-0.5+0.5% Non-immunised12 replicates Immunised (I-Arg-0.5%+Gln-0.5%) 
 
On day 18 of the experiment, chickens were marked with wing tags and 
50% of them in each treatment group were immunised intraperitoneally (100 µg 
bovine serum albumin, BSA, in 200 µl phosphate buffered saline, PBS, mixed 
with 200 µl of incomplete Freund’s adjuvant, Sigma-Aldrich) and the remaining 
birds served as non-immunised controls. 
The individual body weights of the birds were measured on days 18, 25, 
32 and 39. During phase 2, the total feed intake of replicates (6/treatment group) 
was recorded. 
For monitoring the immune response, blood samples (18 samples from im-
munised and 18 from non-immunised chickens/treatment group) were collected 
from the ulnar vein at 18, 28 and 39 days of age. The same wing-tagged chickens 
were used at each sampling time. Serum antibody titres were determined by stan-
dard ELISA protocols using BSA antigen and anti-chicken IgY-HRPO conjugate 
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(SIGMA-Aldrich, 1:10,000). Interferon gamma (IFNG) and interleukin 6 (IL-6) 
levels were measured by the Chicken Interferon gamma and Chicken Interleukin 
6 ELISA kits (Novatein Biosciences, Inc.) following the instructions of the 
manufacturer. Cytokine concentrations were expressed as pg/ml. 
On day 18, 12 chickens and at the end of the experiment 6 immunised and 
6 non-immunised chickens were randomly chosen from each treatment groups 
and exsanguinated under CO2 narcosis. The weight of the different organs (liver, 
spleen, thymus, bursa of Fabricius) was determined. 
The results were expressed as arithmetic means (AVG) ± SD or in natural 
logarithm (LN) ± SD. Statistical analysis of data was performed by one-way 
analysis of variance (ANOVA) with LSD post hoc multiple comparison test. The 
experimental protocol met the standard criteria of the Scientific Ethics Commit-
tee of Animal Experiments of the Faculty of Veterinary Science, Szent István 
University, Budapest, Hungary (registration number: 22.1/613/001/2010). 
 
 
Results and discussion 
Effect of Arg or Gln on the body weight of 18-day-old birds (starter phase) 
The control starter diet contained 1.53% of Arg, 0.46% of Gln and 1.45% 
of Lys. The addition of Arg and/or Gln (0.5% or 1%) to this starter diet did not 
influence the body weight significantly (Table 3), suggesting that the Arg or Gln 
contents of the control starter diet completely covered the Arg requirement of 
broilers during the first 18 days of life. 
Labadan et al. (2001) suggested that, up to two weeks of age, breast mus-
cle growth was the best when the starter diet contained 1.32% Arg (crude protein 
content: 22%) and 1.27% Lys. In our experiment, where the Arg/Lys ratio 
changed from 1:0.95 (control) to 1:0.71 (Arg-0.5%) and 1:0.57 (Arg-1%), the 
excess Arg relative to Lys did not induce any depression of body weight gain; 
however, an antagonism between Arg and excess Lys in the diet had been recog-
nised in poultry (Kadirvel et al., 1974). 
Contrary to our results, Bartell and Batal (2007) reported that, up to 21 
days of age, 1% Gln supplementation improved the body weight gain of broilers 
compared with birds on a corn-soybean meal (SBM) diet. However, in pigs Kitt 
et al. (2002) also reported no improvement in body weight gain as a result of Gln 
supplementation of diet. We may speculate that the complexity of diets used in 
the different experiments, especially in terms of the protein sources in the diets 
(the Gln level of the basal diet), can be important factors regarding the differ-
ences noted. 
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Table 3 
Effect of immunisation on body weight, feed intake and feed conversion ratio of broilers fed diets supplemented with Arg or Gln from 18 to 39 
days of age (different superscripts indicate significant difference at P ≤ 0.05 level) 
  Control Arg-0.5% Arg-1% Gln-0.5% Gln-1% Arg+Gln-0.5+0.5%
  Day 18 (the end of the first experimental phase)  
 BW, g 550.6 ± 64.7 554.5 ± 47.8 552.2 ± 50.9 551.0 ± 43.4 544.2 ± 63.3 524.1 ± 49.5 
Day 18 (the first day of the second phase) Average body weight of broilers after the random distribution into immunised and non-immunised groups 
Non-immunised BW, g 
(%) 
557.2 ± 68.4 
100.0 ± 12.3 
551.4 ± 47.7 
100.0 ± 8.65 
549.9 ± 56.5 
100.0 ± 10.3 
555.6 ± 42.8 
100.0 ± 7.71 
537.1 ± 64.5 
100.0 ± 12.01 
522.1 ± 51.6 
100.0 ± 9.9 
Immunised BW, g 
(%) 
537.4 ± 56.2 
100.0 ± 10.5 
560.7 ± 48.7 
100.0 ± 8.7 
554.3 ± 40.0 
100.0 ± 7.2 
539.7 ± 44.0 
100.0 ± 8.2 
561.3 ± 57.3 
100.0 ± 10.2 
528.1 ± 46.2 
100.0 ± 8.8 
  Day 25  
Non-immunised BW, g 
(%) 
968.7 ± 116.1 
173.9a ± 20.8 
989.0 ± 78.0 
179.4ab ± 14.2 
998.5 ± 109.2 
181.6ab ± 19.8 
997.4 ± 121.8 
179.5a ± 21.9a 
932.1 ± 118.1 
173.6a ± 22.0 
972.2 ± 106.4 
186.2b ± 20.4 
Immunised BW, g 
(%) 
939.7 ± 135.5 
174.9ab ± 25.2 
1015.5 ± 85.1 
181.1b ± 15.2 
1014.8 ± 93.0 
183.1b ± 16.8 
962.8 ± 90.4 
178.4b ± 16.7 
943.4 ± 95.9 
168.1a ± 17.1a 
975.9 ± 95.1 
184.8b ± 18.0 
  Day 32  
Non-immunised BW, g 
(%) 
1550.3 ± 159.9 
278.2a ± 28.7 
1601.6 ± 117.3 
290.4b ± 21.3 
1594.4 ± 163.3 
289.9ab ± 29.7 
1563.6 ± 170.5 
281.4a ± 30.7 
1509.3 ± 177.3 
281.0ab ± 33.0 
1529.5 ± 147.5 
292.9b ± 28.2 
Immunised BW, g 
(%) 
1483.4 ± 183.1 
276.0ab ± 34.1 
1619.6 ± 118.6 
288.8ab ± 21.2 
1627.2 ± 142.2 
293.6ab ± 25.7 
1530.9 ± 165.0 
283.6ab ± 30.6 
1496.9 ± 157.1 
266.7a ± 28.0 
1563.8 ± 152.8 
296.1b ± 28.9 
  Day 39  
Non-immunised BW, g 
(%) 
2138.8 ± 191.1 
383.8a ± 34.3 
2240.8 ± 186.1 
406.4bc ± 33.7 
2200.8 ± 175.4 
400.2bc ± 31.9 
2130.9 ± 247.5 
383.5a ± 44.5 
2104.0 ± 232.6 
391.7ab ± 43.3 
2144.6 ± 194.3 
410.8c ± 37.2 
Immunised BW, g 
(%) 
2046.6 ± 228.1 
380.8a ± 42.4 
2284.1 ± 190.5 
407.4b ± 34.0 
2255.8 ± 204.0 
407.0b ± 36.8 
2114.5 ± 232.7 
391.7b ± 43.1 
2041.6 ± 227.8 
363.7a ± 40.6 
2201.6 ± 203.3 
416.9b ± 38.5 
  Days 18–39 (non-immunised and immunised together)  
Feed intake (g/day/chicken) 137.3 ± 8.79 139.9 ± 5.36 142.5 ± 3.37 139.9 ± 5.42 135.8 ± 4.63 141.5 ± 0.06 
FCR (kg/kg) 1.84ab ± 0.14 1.74a ± 0.06 1.83a ± 0.08 1.88bc ± 0.09 1.97c ± 0.12 1.77a ± 0.07 
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Effect of Arg or Gln supplementation on the body weight of broilers  
between 18 and 39 days of age 
In the second phase of the experiment each of the treatment groups was 
randomly divided into two subgroups (immunised and non-immunised). To di-
minish the slight starting body weight differences among the treatment groups, 
the body weights of chickens on day 18 were regarded as 100%. 
In the non-immunised broilers both the 0.5% and 1% Arg and the Arg-
0.5% + Gln-0.5% supplementations significantly increased the body weight (by 
5.9, 4.3% and 7.0%, respectively) (Fig. 1), suggesting that the Arg level of the 
control grower and finisher diets was not sufficient for the maximum growth of 
broilers in the second phase of the experiment (days 18 to 39). 
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Fig. 1. Time-related effect of diets supplemented with arginine (Arg) and/or glutamine (Glu) on the 
body weight of broilers (* = the difference from the control is significant at P ≤ 0.05 level) 
 
On the basis of our results, around 1.7% Arg in the grower diet may be the 
optimum level, when the protein and Lys content of the diet were 19.7% and 
1.13%, respectively. This Arg level is much higher than the requirement found 
by Labadan et al. (2001) (1.16% Arg and 1.15% Lys) for 3- to 6-week-old broil-
ers. We suggest that, in order to attain the best performance of 3- to 6-week-old 
Ross 308 broilers, the Arg/Lys ratio should be positive, 1.4 to 1.0, at 1.15% Lys 
level in the diet. 
During the same treatment period, 0.5% Gln supplementation did not induce 
any significant effect on the body weight gain of non-immunised broilers; how-
ever, 1% Gln supplementation slightly but not significantly (+2.07%) increased the 
body weight of the non-immunised chickens by the end of the experiment. 
Soltan (2009) reported that by the end of the 6th week the body weight of 
a broiler chicken group receiving 1% Gln supplementation was significantly 
higher than that of the control. Higher Gln supplementation (1.5 and 2%) did not 
induce any significant change relative to the control group. On the other hand, 
Bartell and Batal (2007) found that by day 14, 1% Gln supplementation im-
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proved the body weight gain compared to birds fed a standard corn–soybean 
meal diet. Conversely, 4% Gln supplementation to the diet depressed the per-
formance of chickens. As the 4% Gln supplementation level is much higher than 
the estimated no-observed-adverse-effect level (NOAEL) (Tsubuku et al., 2004) 
for Gln (1.25% for rats), it can be supposed that this negative effect may be the 
result of Gln toxicity. Based on the data reported by others and our data pre-
sented here, Gln supplementation levels higher than 1% are not recommended in 
broiler diets; however, this may depend on the Gln content of the basal diet. 
Effect of immunisation and Arg or Gln supplementation on the body weight  
of broilers between 18 and 39 days of age 
In the second phase of the experiment (3 to 6 weeks), immunisation 
slightly depressed the growth of broilers (–0.79%) receiving the control diet; 
however, these differences were not statistically significant (Fig. 2). When the 
diets of immunised chickens were supplemented with Arg (0.5 or 1%), Gln 
(0.5%) or with the combination of Arg and Gln (0.5% + 0.5%), the immunisation 
induced a slight growth depression which was then not only compensated but 
turned into a positive direction. 
These immunised chickens grew as well as, or even better (by 6.33%, 
6.13%, 2.07% and 8.60% in the I-Arg-1%, I-Arg-0.5%, I-Gln-0.5% or Arg-0.5% 
+ Gln-0.5% groups, respectively) than the non-immunised chickens receiving the 
same diet (Arg-0.5%: 5.87%, Arg-1%: 4.27%, Gln-1%: 2.07% and Arg-0.5% + 
Gln-0.5%: 7.04%) (Fig. 2). This suggests that the immunisation itself stimulates 
the protein turnover of the animals. Garlick et al. (1980) noted a 37% increase in 
protein synthesis and a 55% increase of protein degradation after vaccination. 
We may assume that the higher Arg levels of the supplemented diets covered the 
immunisation-generated extra amino acid and/or energy requirement of the im-
mune system. 
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Fig. 2. Time-related effect of immunisation on the body weight of broilers fed Arg- and/or  
Gln-supplemented diets (* = the difference from the control is significant at P ≤ 0.05 level) 
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It is interesting that in the non-immunised broilers the higher (1%) and in 
the immunised chickens the lower (0.5%) dose of Gln supplementation induced a 
slight (2.07%) but not significant increase in body weight. Contrary to this, 1% Gln 
supplementation significantly (P < 0.05) depressed (–5.13%) the body weight gain 
of the immunised chickens (Fig. 2); moreover, this depression was significantly 
stronger (–5.13%) than in chickens of the I-Control group (–0.79%). The statistical 
analysis clearly shows that there was a strongly significant difference between the 
immunised and non-immunised chickens regarding Gln on the body weight. 
We suggest that this negative effect was in accordance with the magnitude 
of the immune response, which was significantly higher in the I-Gln-1% group 
than in the I-Control animals (Table 5). This is in accordance with the findings that 
Gln is required for lymphocyte proliferation (Wu et al., 1992) in a dose-dependent 
manner and it is catabolised by the glutaminolytic pathway to yield glutamate and 
other metabolites for cells of the immune system, including thymocytes, blood 
lymphocytes, intraepithelial lymphocytes, neutrophils and macrophages (Li et al., 
2007). Because the Gln derived from the diet is almost completely utilised by cells 
of the intestine, the Gln necessary for the extraintestinal lymphocytes and other 
rapidly dividing cells may come from the amino acid metabolism in muscles 
(Newsholme et al., 1985). If the body uses more glutamine than it can produce (i.e. 
during times of increased immune reactions), muscle wasting can occur because 
muscle is the primary site for Gln. This can be an explanation for the slight growth 
depression observed after immunisation. 
Effect of dietary Arg or Gln supplementation on feed intake and feed  
conversion ratio (FCR) between 18 to 39 days of age in broilers 
Because immunised and non-immunised chickens were housed and fed to-
gether in each treatment group, the feed intake and consequently the FCR were not 
determined separately. Table 3 indicates the effect of Arg or Gln supplementation on 
feed intake of the mixed (immunised and non-immunised) populations of chickens. 
The supplementation of grower and finisher diets with Arg or Gln or with 
the combination thereof did not influence the feed intake significantly. Regarding 
Arg, our result is different from the findings of Al-Daraji and Salih (2012), who 
reported that Arg supplementation (0.02%, 0.04% and 0.06% of the diet) signifi-
cantly increased the feed intake of broilers. An explanation of these conflicting 
results may be the 10 and 20 times higher levels (0.5% and 1.0%) of supplemen-
tation used in the current study. Another confounding factor may be that the feed 
intakes of immunised and non-immunised chickens were not determined sepa-
rately. However, data reported by others indicate that immunisation did not in-
fluence the feed intake and FCR of broilers (El-Sayed et al., 2011). In an experi-
ment with pigs, Hagemeier et al. (1983) studied the effect of three Arg levels 
(0.94%, 1.29% and 1.63%) similar to the doses used in our study, and they found 
that Arg had no effect on the daily feed intake.  
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Table 4 
Effect of Arg or Gln supplementation of the diets on organ weights of immunised chickens (different superscripts indicate significant difference at 
P ≤ 0.05 level) 
NI-Control I-Control I-Arg-0.5% I-Arg-1% I-Gln-0.5% I-Gln-1% I-Arg+Gln-0.5+0.5%  
(g/100 g BW) 
Liver 2.16b ± 0.19 1.86a ± 0.16 2.11b ± 0.05 2.23b ± 0.33 2.10ab ± 0.27 2.15b ± 0.14 1.98ab ± 0.18 
Spleen 0.089ab ± 0.018 0.104ab ± 0.028 0.094ab ± 0.014 0.074a ± 0.023 0.114b ± 0.027 0.107ab ± 0.033 0.085ab ± 0.025
Thymus 0.137a ± 0.023 0.163ab ± 0.041 0.200b ± 0.044 0.153ab ± 0.035 0.180ab ± 0.017 0.199b ± 0.027 0.162ab ± 0.073
Bursa of Fabricius 0.215a ± 0.027 0.315b ± 0.042 0.237a ± 0.024 0.262ab ± 0.055 0.249ab ± 0.081 0.346b ± 0.122 0.242ab ± 0.056
 
Table 5 
Effect of Arg or Gln on anti-albumin IgY-titre, IL-6 and IFNG level of immunised chickens (different superscripts indicate significant difference at 
P ≤ 0.05 level) 
Immunised 
 
Sampling time 
(days after  
immunisation) I-Control I-Arg-0.5% I-Arg-1% I-Gln-0.5% I-Gln-1% 
I-Arg + Gln 
0.5+0.5% 
10 5.82a ± 1.22 6.13a ± 4.4 5.83a ± 1.14 5.93a ± 1.12 6.96b ± 0.67 6.04a ± 1.28Antibody titre 
(Average LN ± SD) 21 5.30 ± 0.98 5.74 ± 1.17 5.09 ± 0.97 5.38 ± 1.36 5.76 ± 1.59 5.64 ± 1.07 
10 154.± 23 172.± 36 173.± 65 186.± 47 161.± 53 192.± 56 IL-6 (pg/ml) 21 101.± 22 129.± 32 132.± 15 121.± 22 114.± 34 111.± 37 
10 632.± 89 325.± 114 337.± 200 411.± 171 480.± 289 340.± 131 IFNG (pg/ml) 
21 638.± 501 607.± 148 607.± 361 426.± 194 764.± 209 679.± 306 
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Bartell and Batal (2007) reported that the effect of Gln on the FCR was 
not consistent. One percent Gln supplementation decreased but 4% Gln supple-
mentation increased the FCR. In our experiment there was a significant differ-
ence between the Arg- and Gln-supplemented groups in terms of FCR. While 
Arg and the combination of Arg and Gln slightly but not significantly decreased 
(improved), Gln-1% significantly increased (worsened) the FCR (Table 3) be-
tween 18 and 39 days of age. Based on the body weight gain, feed intake and 
FCR data, 1.7% Arg in the grower diet (1.25% original Arg level + 0.5% Arg sup-
plementation) resulted in the best production parameters. Because Arg is a potent 
secretagogue for insulin (Newsholme et al., 2005), growth hormone and insulin-
like growth factor, and it also stimulated the body weight gain and improved the 
feed efficiency of both non-immunised and immunised broilers, we propose that 
Arg is a potent growth promoter for broilers and the supplementation of grower di-
ets with Arg should be incorporated in the poultry nutrition practice. 
Effect of dietary Arg or Gln supplementation on the organ weights of broilers 
Arg or Gln supplementations did not induce any significant change in or-
gan weights during the first phase of the experiment. This result is in agreement 
with the data of Deng et al. (2003), i.e. that low (0.67%; 70% of the NRC rec-
ommendations) or high (1.21%; 130% of the NRC recommendations; National 
Research Council, 1994) dietary Arg levels did not induce any significant differ-
ences in the weight of organs (either lymphoid or non-lymphoid tissues) during 
the starter phase. In contrast to this, Kwak et al. (1999) reported that Arg mark-
edly influenced the development of lymphoid organs, with a more pronounced 
effect on the thymus and spleen than on the bursa of Fabricius. They reported 
that an Arg-deficient diet reduced the body weight gain and the weights of the 
thymus, spleen and bursa of Fabricius. A small (0.2%) dietary Arg supplementa-
tion (at 0.73% dietary Arg level) was sufficient to support the development of 
body and lymphoid organs of chickens. 
In the second phase of our experiment (days 18–39), in chickens fed the 
control diet, the immunisation significantly (P < 0.05) decreased the weight of 
the liver (Table 4, Fig. 3). On the other hand, the weight of the bursa of Fabricius 
was significantly higher than in the control birds. The weights of spleen and 
thymus tended to be higher than in the non-immunised control birds; however, 
these increases were not significant. These results suggest that in the immunised 
animals a higher proportion of the dietary amino acids and energy was used in 
the lymphoid organs and less were supplied to the liver. 
The data presented in Table 4 indicate that the elevated dietary Arg level 
(Arg-1%) decreased the effect of immunisation on the organs studied. The 
weights of the liver were significantly (P < 0.05) higher while the weight of the 
bursa of Fabricius was lower than in the immunised birds fed the control diet. 
Gln and Arg supplementation induced similar weight changes in the liver. The 
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effect of Gln on the lymphoid organs was not significant. The effect of Arg on 
the lymphoid organs depended on the dose and the organ (Arg-1% decreased the 
weight of the spleen and Arg-0.5% increased the weight of thymus significantly). 
Immunised broilers
on control diet
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Fig. 3. Effect of immunisation on organ weights of broilers (* = the difference from the control is 
significant at P ≤ 0.05 level) 
Effect of Arg or Gln supplementation of the diets on the anti-albumin IgY titre  
as well as IL-6 and IFNG levels of broilers 
As compared to the control, both Arg and Gln supplementation increased 
the antibody titres; however, the increase was significant only for the Gln-1% 
group (P < 0.05) 10 days after the immunisation. By the end of the experiment 
the antibody titre decreased in each treatment group (Table 5). 
The anti-albumin IgY titre clearly followed the general primary humoral 
immune response. The differences in these antibody levels detected at the two 
time-points of sampling indicated that both Arg and Gln supplementation in-
creased the specific immune response to the given antigen, resulting in not only a 
stronger but also a longer-lasting protection. 
The IL-6 and IFNG data showed a negative correlation 10 days after im-
munisation (R = –0.726). This result is not surprising since IFNG is well known 
to decrease T helper (Th) 2 type cytokine production (Schroder et al., 2004) in-
cluding IL-6 synthesis. 
Based on the results presented above it can be concluded that, during the 
starter phase, Arg or Gln supplementation of the diets influenced neither the pro-
duction parameters nor the organ weights until 18 days of age, suggesting that 
the Arg and Gln content of the starter diet adequately covered the requirements 
of Ross 308 broilers. In the grower and finisher phases (days 19–39), both Arg 
(0.5 and 1%) and the Arg + Gln supplementation of the diets significantly im-
proved the production parameters, suggesting that the Arg requirement of the Ross 
308 broilers in that production period is higher than the recommended 1.2% level. 
The slight depression of growth induced by immunisation was not only 
compensated but turned into a positive direction by Arg (0.5% or 1%), Gln 
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(0.5%) or Arg + Gln (0.5 + 0.5%) supplementation of the grower and finisher di-
ets. The addition of 1% Gln supplementation significantly (P < 0.05) depressed 
(–4.49%) the body weight gain of the immunised chickens. Supplementation of 
the grower and finisher diets with 1% Gln stimulated the immune response very 
effectively; however, the body weight gain was significantly lower than in the 
non-immunised and immunised control groups. 
In the grower and finisher phases, immunisation significantly (P < 0.05) de-
creased the weight of the liver; however, the weights of the thymus and the bursa 
of Fabricius were higher than in the control birds. Measurements of cytokine lev-
els indicated that 10 days after the immunisation there was a significant negative 
correlation between IL-6 and IFNG. Regarding production, organ weights and 
immunity, Arg supplementation should be recommended in the grower phase; 
Arg seemed to be a good growth promoter for both the immunised and the con-
trol birds. Gln supplementation can be useful in pullets raised for egg production, 
where a good immune response to vaccinations is an important factor. 
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